These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15577612)

  • 1. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis.
    Postlethwaite AE; Shigemitsu H; Kanangat S
    Curr Opin Rheumatol; 2004 Nov; 16(6):733-8. PubMed ID: 15577612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.
    Wei J; Bhattacharyya S; Tourtellotte WG; Varga J
    Autoimmun Rev; 2011 Mar; 10(5):267-75. PubMed ID: 20863909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
    Liu T; Hu XD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting.
    Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
    Curr Mol Med; 2022; 22(3):209-239. PubMed ID: 33823766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of fibrosing cells in systemic sclerosis.
    Ebmeier S; Horsley V
    Curr Opin Rheumatol; 2015 Nov; 27(6):555-62. PubMed ID: 26352735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.
    Rajkumar VS; Howell K; Csiszar K; Denton CP; Black CM; Abraham DJ
    Arthritis Res Ther; 2005; 7(5):R1113-23. PubMed ID: 16207328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells.
    Gilbane AJ; Denton CP; Holmes AM
    Arthritis Res Ther; 2013; 15(3):215. PubMed ID: 23796020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in fibroblast signaling and biology in scleroderma.
    Pannu J; Trojanowska M
    Curr Opin Rheumatol; 2004 Nov; 16(6):739-45. PubMed ID: 15577613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
    Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
    Sun YB; Qu X; Caruana G; Li J
    Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular mechanisms of fibrosis.
    Wynn TA
    J Pathol; 2008 Jan; 214(2):199-210. PubMed ID: 18161745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.